Floatz logo

Semaglutide

Sleep Apnea Syndrome (OSAS)

Shanghai Fengxian District Central Hospitalprotein_peptideActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Sleep Apnea Syndrome (OSAS) cohort.

Asset / SponsorPhaseRating
Adalimumab
Innovaderm Research Inc.
Phase 4BB
MELATONIN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 4BB
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
xw003
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3B
nnc0487-0111
Novo Nordisk A/S
Phase 3B

View all 16 →

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →